Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wm Kevin Kelly

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Prostate Cancer and Prostatic Diseases|February 23, 2022
Substantial Gleason reclassification in Black men with national comprehensive cancer network low-risk prostate cancer - A propensity score analysisShivanshu Awasthi, Brandon A Mahal, Jong Y Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2021
A Randomized Phase II Study of Androgen Deprivation Therapy with or without Palbociclib in RB-positive Metastatic Hormone-Sensitive Prostate CancerPhillip L Palmbos, Stephanie Daignault-Newton, Scott A Tomlins, et al.
Molecular Cancer Research : MCR|April 27, 2025
Exploring STEAP1 Expression in Prostate Cancer Cells in Response to Androgen Deprivation and in Small Extracellular VesiclesCandice L Bizzaro, Camila A Bach, Ricardo A Santos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2018
MAPK Reliance via Acquired CDK4/6 Inhibitor Resistance in CancerRenée de Leeuw, Christopher McNair, Matthew J Schiewer, et al.
Molecular Oncology|September 7, 2025
PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration-resistant prostate cancerMoriah L Cunningham, Jasibel Vasquez-Gonzalez, Samantha M Barnada, et al.
EMBO Molecular Medicine|November 24, 2018
PARP-1 regulates DNA repair factor availabilityMatthew J Schiewer, Amy C Mandigo, Nicolas Gordon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2016
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3Howard I Scher, Michael J Morris, Walter M Stadler, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Prostate Cancer and Prostatic Diseases|February 23, 2022
Substantial Gleason reclassification in Black men with national comprehensive cancer network low-risk prostate cancer - A propensity score analysisShivanshu Awasthi, Brandon A Mahal, Jong Y Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2021
A Randomized Phase II Study of Androgen Deprivation Therapy with or without Palbociclib in RB-positive Metastatic Hormone-Sensitive Prostate CancerPhillip L Palmbos, Stephanie Daignault-Newton, Scott A Tomlins, et al.
Molecular Cancer Research : MCR|April 27, 2025
Exploring STEAP1 Expression in Prostate Cancer Cells in Response to Androgen Deprivation and in Small Extracellular VesiclesCandice L Bizzaro, Camila A Bach, Ricardo A Santos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2018
MAPK Reliance via Acquired CDK4/6 Inhibitor Resistance in CancerRenée de Leeuw, Christopher McNair, Matthew J Schiewer, et al.
Molecular Oncology|September 7, 2025
PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration-resistant prostate cancerMoriah L Cunningham, Jasibel Vasquez-Gonzalez, Samantha M Barnada, et al.
EMBO Molecular Medicine|November 24, 2018
PARP-1 regulates DNA repair factor availabilityMatthew J Schiewer, Amy C Mandigo, Nicolas Gordon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2016
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3Howard I Scher, Michael J Morris, Walter M Stadler, et al.
Pageof 4